Log In
Print
BCIQ
Print
Print this Print this
 

Endostar (Endu, Rh-Endostatin)

  Manage Alerts
Collapse Summary General Information
Company Simcere Pharmaceutical Group
DescriptionRecombinant human endostatin injection
Molecular Target Endostatin
Mechanism of ActionAngiogenesis inhibitor
Therapeutic ModalityBiologic: Protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$539.4M

$539.4M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today